Funder
Korea Health Industry Development Institute
Ministry of Health and Welfare
Reference24 articles.
1. The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity;Jan Borén;Curr. Opin.Lipidology,2016
2. ESC scientific document group, 2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk;Francois;Eur. Hear J.,2020
3. Residual cardiovascular risk despite optimal LDL cholesterol reduction with statins: the evidence, etiology, and therapeutic challenges;Uchechukwu;Curr. Atherosclerosis Rep.,2012
4. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of blood cholesterol;al;J. Am. Coll. Cardiol.,2019
5. Nutraceuticals in the management of dyslipidemia: which, when, and for whom? Could nutraceuticals help low-risk individuals with non-optimal lipid levels?;Cicero;Curr. Atherosclerosis Rep.,2021